Is LL-37 legal in District of Columbia?
status · caveats apply
Endogenous antimicrobial peptide; investigational analogs in early trials; no approved synthetic LL-37 product; not on WADA list. No state-level peptide restrictions beyond federal law in District of Columbia.
category: no approval · last verified May 13, 2026
§ 01
Quick answer
Endogenous antimicrobial peptide; investigational analogs in early trials; no approved synthetic LL-37 product; not on WADA list. No state-level peptide restrictions beyond federal law in District of Columbia.
§ 02
Full status breakdown
Federal status
FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
FDA Warning Letters
none on record for this compound
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Unapproved; FDCA applies.
Personal possession: Not federally criminalized.
District of Columbia — state-specific
Sport-body status
WADA 2026
USADA
unknown
NCAA
unknown
What we couldn’t verify
§ 03
Also known as
LL-37 is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):
CathelicidinHuman Cathelicidin Antimicrobial PeptidehCAP-18 fragmentCAMPFALL-39
§ 04
Disclaimer
§ 05
Related
- Back to peptide legality lookup — pick a different compound or state
- Peptide pricing index — what each compound costs per mg across audited vendors
- Janoshik COA verifier — a separate question from legality: does the COA the vendor cites actually exist?
the roundup · monthly
Receipts in your inbox. Once a month.
New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.
14,200 subscribers· 0 sponsored items· 11 issues since launch